NR4A1 and experimental autoimmune encephalomyelitis: Moreover, the loss of NR4A1 enhanced experimental autoimmune encephalomyelitis in mice compared to wild-type mice, and in mice expressing NR4A1, treatment with CsnB inhibited the course of this disease model for multiple sclerosis.